ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,460.48
      -0.41%
      US Tech 100
      19,181.60
      -0.43%
      Dow Jones
      39,118.86
      -0.12%
      Brent Oil
      84.85
      0.00%
      Bitcoin
      61,556.18
      1.09%
      Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Adamas Pharmaceuticals Inc (ADMS)

      7. Adamas Pharmaceuticals Inc (ADMS) News

      ADMS

      Adamas Pharmaceuticals (ADMS)

      Adamas Pharmaceuticals Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:ADMS
      DateTimeSourceHeadlineSymbolCompany
      06/22/20157:21PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ADMSAdamas Pharmaceuticals Inc
      06/17/20154:49PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ADMSAdamas Pharmaceuticals Inc
      06/09/20156:13PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ADMSAdamas Pharmaceuticals Inc
      06/09/20156:06PMEdgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:ADMSAdamas Pharmaceuticals Inc
      06/09/20155:55PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ADMSAdamas Pharmaceuticals Inc
      06/03/20155:30PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ADMSAdamas Pharmaceuticals Inc
      06/02/20156:02AMEdgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:ADMSAdamas Pharmaceuticals Inc
      06/02/20156:01AMEdgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:ADMSAdamas Pharmaceuticals Inc
      06/01/20155:29PMEdgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:ADMSAdamas Pharmaceuticals Inc
      05/19/20154:07PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ADMSAdamas Pharmaceuticals Inc
      05/19/20156:01AMEdgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)NASDAQ:ADMSAdamas Pharmaceuticals Inc
      05/18/20155:30PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ADMSAdamas Pharmaceuticals Inc
      05/18/20155:27PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ADMSAdamas Pharmaceuticals Inc
      05/18/20155:24PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ADMSAdamas Pharmaceuticals Inc
      05/18/20155:20PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ADMSAdamas Pharmaceuticals Inc
      05/18/20155:14PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ADMSAdamas Pharmaceuticals Inc
      05/18/20155:09PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ADMSAdamas Pharmaceuticals Inc
      05/18/20155:01PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ADMSAdamas Pharmaceuticals Inc
      05/18/20158:00AMPR Newswire (US)Actavis Launches NAMZARIC™ (memantine hydrochloride extended-release and donepezil hydrochloride), a Fixed-Dose Combination...NASDAQ:ADMSAdamas Pharmaceuticals Inc
      05/14/20157:49PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ADMSAdamas Pharmaceuticals Inc
      05/13/20154:07PMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:ADMSAdamas Pharmaceuticals Inc
      05/13/20154:05PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ADMSAdamas Pharmaceuticals Inc
      05/13/20154:00PMGlobeNewswire Inc.Adamas Reports First Quarter 2015 Financial ResultsNASDAQ:ADMSAdamas Pharmaceuticals Inc
      05/07/20154:53PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ADMSAdamas Pharmaceuticals Inc
      05/06/20155:06PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ADMSAdamas Pharmaceuticals Inc
      04/27/20155:15PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ADMSAdamas Pharmaceuticals Inc
      04/22/20157:01PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ADMSAdamas Pharmaceuticals Inc
      04/16/20154:44PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ADMSAdamas Pharmaceuticals Inc
      04/14/20157:34PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ADMSAdamas Pharmaceuticals Inc
      04/10/20158:30AMGlobeNewswire Inc.Adamas Pharmaceuticals Receives Orphan Drug Designation for ADS-5102 for the Treatment of Levodopa-Induced Dyskinesia Associa...NASDAQ:ADMSAdamas Pharmaceuticals Inc
       Showing the most relevant articles for your search:NASDAQ:ADMS